Metabolic changes in plasma and immune cells associated with COVID-19 severity, can predict patient survival

cell
Credit: CC0 Public Domain

COVID-19 patients have differing immune responses that lead to disease outcomes ranging from asymptomatic SARS-CoV-2 infection to death. After examining the blood samples from nearly 200 COVID-19 patients, researchers have uncovered underlying metabolic changes that regulate how immune cells react to the disease. These changes are associated with disease severity and could be used to predict patient survival. The findings were published in the journal Nature Biotechnology.

"We know that there are a range of immune responses to COVID-19, and the biological processes underlying those responses are not well understood," said co-first author Jihoon Lee, a graduate student at Fred Hutchinson Cancer Research Center. "We analyzed thousands of biological markers linked to that underlie the and found some clues as to what immune- may be pivotal in severe disease. Our hope is that these observations of immune function will help others piece together the body's response to COVID-19. The deeper understanding gained here may eventually lead to better therapies that can more precisely target the most problematic immune or metabolic changes."

The researchers collected 374 —two draws per patient during the first week after being diagnosed with SARS-CoV-2 infection—and analyzed their plasma and single . The analysis included 1,387 genes involved in metabolic pathways and 1,050 plasma metabolites.

In plasma samples, the team found that increased COVID-19 severity is associated with metabolite alterations, suggesting increased immune-related activity. Furthermore, through single-cell sequencing, researchers found that each major immune cell type has a distinct metabolic signature.

"We have found metabolic reprogramming that is highly specific to individual immune cell classes (e.g. "killer" CD8+ T cells, "helper" CD4+ T cells, antibody-secreting B cells, etc.) and even cell subtypes, and the complex metabolic reprogramming of the immune system is associated with the plasma global metabolome and are predictive of disease severity and even patient death," said co-first and co-corresponding author Dr. Yapeng Su, a research scientist at Institute for Systems Biology. "Such deep and clinically relevant insights on sophisticated metabolic reprogramming within our heterogeneous immune systems are otherwise impossible to gain without advanced single-cell multi-omic analysis."

"This work provides significant insights for developing more effective treatments against COVID-19. It also represents a major technological hurdle," said Dr. Jim Heath, president and professor of ISB and co-corresponding author on the paper. "Many of the that are collected from these patients tend to measure very different aspects of the disease, and are analyzed in isolation. Of course, one would like these different views to contribute to an overall picture of the patient. The approach described here allows for the sum of the different data sets to be much greater than the parts, and provides for a much richer interpretation of the disease."

The research was conducted by scientists from ISB, Fred Hutchinson Cancer Research Center, Stanford University, Swedish Medical Center St. John's Cancer Institute at Saint John's Health Center, the University of Washington, the Howard Hughes Medical Institute.


Explore further

Macrophages play key role in lung damage during COVID-19

More information: Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19, Nature Biotechnology (2021). DOI: 10.1038/s41587-021-01020-4 , www.nature.com/articles/s41587-021-01020-4
Journal information: Nature Biotechnology

Provided by Institute for Systems Biology
Citation: Metabolic changes in plasma and immune cells associated with COVID-19 severity, can predict patient survival (2021, September 6) retrieved 27 October 2021 from https://medicalxpress.com/news/2021-09-metabolic-plasma-immune-cells-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
362 shares

Feedback to editors